Meinntech has signed a clinical validation contract in January with Yonsei University Severance to establish a platform for advancement into the global market with reference and evidence of clinical reliability of Anyfusion.

We also have contracted with Seoul National University Bundang Hospital and Gachon Gil Hospital to carry out tests to ensure reliability of safety and efficacy of Anyfusion in various clinical fields.

We would like to conduct a demo at Busan Donga University, Jeju University Hospital, Jeonbuk University Hospital, Fatima Hospital, and Daegu Catholic University Hospital.

In overseas, we have decided to proceed with the demonstration in Malaysia on March 15 to 16, in Saudi Arabia 3 cities on March 20 to 30.

If Anyfusion’s productive strengths of almost 100% accuracy for 72 hours, reduced alarm of 1/3~1/10, no need to replace syringe or IV set frequently, and safety through the first demonstration in these domestic and overseas hospitals, and the clinical trials at Seoul National University, Yonsei University, Gachon University; it is anticipated to replace the existing products.

Anyfusion’s reputation is expected to become unpredictable, when clinical trial results from abroad are generalized after 2017.

We will actively promote the marketization that was suspended due to the calculation issue of the HIRA (Health Insurance Review & Assessment Services).

Thank you.